Author

Arend Moll

Observed names: A Moll, A. Moll, Moll, A.

OpenAlex ID: A5048783682

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

2007 · Adriano Lazzarin, Thomas Campbell, et al. · The Lancet · 393

A highly virulent variant of HIV-1 circulating in the Netherlands

2022 · Chris Wymant, Daniela Bezemer, et al. · Science · 72

Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral ( DAA )‐based hepatitis C virus ( HCV ) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?

2018 · J Bischoff, S Mauss, et al. · HIV Medicine · 47

Considerable Under-Treatment of Chronic HCV Infection in HIV Patients despite Acceptable Sustained Virological Response Rates in a Real-Life Setting

2011 · Thomas Reiberger, Martin Obermeier, et al. · Antiviral Therapy · 34

HIV and Cancer in Germany

2011 · Manfred Hensel, Armin Goetzenich, et al. · Deutsches Ärzteblatt international · 23

Similar efficacy and tolerability of raltegravir-based antiretroviral therapy in HIV-infected patients, irrespective of age group, burden of comorbidities and concomitant medication: Real-life analysis of the German ‘WIP’ cohort

2016 · U Naumann, A Moll, et al. · International Journal of STD & AIDS · 18

Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): The "Real-life Setting" proves the concept

2011 · M Obermeier, P Ingiliz, et al. · European journal of medical research · 16

The patient cohort of the German competence network for HIV/AIDS (KompNet):a profile

2009 · K Jansen, C Michalik, et al. · European journal of medical research · 16

HIV transmission despite HIV post-exposure prophylaxis after non-occupational exposure

2004 · Christiane Cordes, Arend Moll, et al. · AIDS · 9

Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2%

2019 · U Naumann, A Moll, et al. · International Journal of STD & AIDS · 2

P1146 VIROLOGICAL RESPONSE AND TOLERANCE TO BOCEPREVIR OR TELAPREVIR PLUS PEGINTERFERON ALFA-2a/RIBAVIRIN TRIPLE THERAPY IN HIV–HCV CO-INFECTED PATIENTS: REAL-LIFE FINDINGS FROM THE PAN STUDY

2014 · A. Baumgarten, S. Holm, et al. · Journal of Hepatology

P2.126 Kaposi´S Sarcoma Patient Profile in the Cohort of the German Competence Netzwork HIV/AIDS

2013 · R E Scheitz, S Esser, et al. · Sexually Transmitted Infections

436 Acute Hepatitis C in Persons Infected With the Human Immunodeficiency Virus (hiv): the “real-life Setting” Proves the Concept

2011 · P. Ingiliz, M. Obemeier, et al. · Journal of Hepatology

Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the ‘real‐life setting’ proves the concept

2010 · P Ingiliz, MJ Obermeier, et al. · Journal of the International AIDS Society

Safety and efficacy of tipranavir co-administered with low-dose ritonavir in patients with advanced HIV-1 infection and limited treatment options

2008 · S Esser, A Moll, et al. · Journal of the International AIDS Society

Works count: 16

Citation count: 630

H-index: 9

I10-index: 8